Author

Xiaoyan Ding

Army Medical UniversityORCID 0000-0003-0484-2750Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiaoyan Ding1 paper · Jiangsu Lihua Foods Group Co. Ltd. (China)

Biology Disciplines

Click to filter author papers

Synthetic Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:multiome· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:protein design· 1 Approach:statistical model· 1

Frequent Co-Authors

Shan GuaniD· 3 shared Joseph RoseneckeriD· 2 shared Rui Liao· 2 shared Chao LiiD· 1 shared Dandan ZhangiD· 1 shared Dian HeiD· 1 shared Giovana Bampi· 1 shared Hua Dong· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersSynthetic Biology

Shan GuanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Synthetic BiologybioRxivPreprintJul 10, 2026

Deoxyribonucleotide incorporation reshapes mRNA design beyond canonical ribonucleotide boundaries

Xiaoyan Ding, Rui Liao, Giovana Bampi…·Joseph Rosenecker

This paper shows that substituting ribonucleotides with deoxyribonucleotides in mRNA improves translation efficiency and therapeutic potential in vivo.

DOI 10.64898/2026.07.09.737403

multiomeexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintDec 31, 2024

Flaviviruses Hijack HuR to Suppress CNPY3: A Novel Pathway for Immune Evasion and Therapeutic Intervention

Xiaoyan Ding, Jianguo He, Jing Zhao…·Jintao Li

This study identifies CNPY3 as an antiviral mediator suppressed by flaviviruses via HuR-mediated mRNA destabilization and demonstrates LNP-CNPY3 as a therapeutic approach to enhance antiviral responses.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintSep 22, 2024

Airway applied IVT mRNA vaccine needs specific sequence design and high standard purification that removes devastating dsRNA contaminant

Jingjing Zhang, Chao Li, Yuheng Liu…·Shan Guan

This study shows airway mRNA vaccines need better purification and sequence design to avoid dsRNA contaminants, leading to improved immune responses.

1 citation

𝕏 PostBluesky